Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: Bi-annual CDTI Sponsor: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: bi-annual CDTI Sponsors: Universiteit Antwerpen; Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: Bi-annual CDTI Sponsor: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: bi-annual CDTI Sponsors: Universiteit Antwerpen; Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: Bi-annual CDTI Sponsor: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: bi-annual CDTI Sponsors: Universiteit Antwerpen; Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: Bi-annual CDTI Sponsor: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: bi-annual CDTI Sponsors: Universiteit Antwerpen; Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: Bi-annual CDTI Sponsor: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: bi-annual CDTI Sponsors: Universiteit Antwerpen; Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: Bi-annual CDTI Sponsor: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions: Onchocerciasis; Epilepsy Intervention: Drug: bi-annual CDTI Sponsors: Universiteit Antwerpen; Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials